Return to content in this issue


Efficacy of Therapeutic Plasma Exchange in Severe Immune Hemolytic Anemia Induced by a Carboplatin Desensitization Procedure

Vilà-Nadal G1*, Fiandor Román A1,2,3, Heredia Revuelto R1, Hernández-Maraver D4, Kerguelen Fuentes AE4, Ramírez García E2,3,5,6, Cabañas Moreno R1,2,3,7

1Allergy Unit, Hospital Universitario La Paz, Madrid, Spain
2Institute for Health Research (IdiPAZ), Madrid, Spain
3PIELenRed Consortium
4Department of Haematology, Transfusion Centre and Tissue Bank, Hospital Universitario La Paz, Madrid, Spain
5Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain
6Pharmacology Department, School of Medicine, Universidad Autónoma de Madrid, Spain
7Centro de Investigación en Red de Enfermedades Raras (CIBERER, U754)
*Currently: Allergy & Clinical Immunology, Royal Brompton Hospital, London, UK

J Investig Allergol Clin Immunol 2021; Vol 31(2) : 178-179
doi: 10.18176/jiaci.0634

Key words: Drug-induced immune hemolytic anemia, Immunohematology, Carboplatin, Therapeutic apheresis